C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity
Authors:
- 1 June 2011
- journal article
- Published by Elsevier in Virus Research
- Vol. 158 (1-2) , 235-245
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Innate immune recognition and activation during HIV infectionRetrovirology, 2010
- HIV-1 Lentiviral Vector Immunogenicity Is Mediated by Toll-Like Receptor 3 (TLR3) and TLR7Journal of Virology, 2010
- In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccineArchives of Virology, 2009
- With Minimal Systemic T-Cell Expansion, CD8+T Cells Mediate Protection of Rhesus Macaques Immunized with Attenuated Simian-Human Immunodeficiency Virus SHIV89.6 from Vaginal Challenge with Simian Immunodeficiency VirusJournal of Virology, 2008
- Immunity and protection by live attenuated HIV/SIV vaccinesVirology, 2008
- Role of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein in Cell-Cell Fusion and Virus InfectionJournal of Virology, 2008
- Vaccine Protection by Live, Attenuated Simian Immunodeficiency Virus in the Absence of High-Titer Antibody Responses and High-Frequency Cellular Immune Responses Measurable in the PeripheryJournal of Virology, 2008
- Cytopathic Mechanisms of HIV-1Virology Journal, 2007
- Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccinesVaccine, 2007
- In vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearanceBlood, 2006